Chabiotech Co Ltd (085660)

Currency in KRW
16,900
-190(-1.11%)
Closed·
085660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16,86017,440
52 wk Range
9,69023,950
Key Statistics
Bid/Ask
16,900.00 / 16,910.00
Prev. Close
16,900
Open
17,270
Day's Range
16,860-17,440
52 wk Range
9,690-23,950
Volume
366.67K
Average Volume (3m)
509.23K
1-Year Change
53.3575%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
085660 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 20, 2026
EPS / Forecast
-246.30 / --
Revenue / Forecast
346.54B / --
EPS Revisions
Last 90 days

085660 Income Statement

Compare 085660 to Peers and Sector

Metrics to compare
085660
Peers
Sector
Relationship
P/E Ratio
−14.2x4.3x−0.5x
PEG Ratio
0.010.010.00
Price/Book
5.1x1.8x2.6x
Price / LTM Sales
1.2x1.9x3.3x
Upside (Analyst Target)
-33.6%47.1%
Fair Value Upside
Unlock15.1%6.2%Unlock

Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience. It offers optimized IT system construction and operation; consulting services for development, operation, and expansion of Chaum model; and solutions for maternal-centered genome testing and personalized healthcare. In addition, the company develops immune cells, such as CBT101 for recurrent glioblastoma and solid cancer, and CBT111 and CAR-NK for solid cancer; and stem cells, including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson’s disease, and hESC-RPE for macular degeneration and Stargardt’s disease. Further, it offers IVF (fertility) services; cosmetics and cosmetic raw materials; medical devices and supplies; bioinsurance storage; research services; and other services. The company was founded in 2002 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.95M4.27%66.67B
Other Institutional Investors
20.87M22.57%352.78B
Public Companies & Retail Investors
67.68M73.17%1.14T
Total
92.5M100.00%1.56T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
K. H. Green Co., Ltd.9.41%8,701,938147,062,752
Hanwha Asset Management Co. Ltd.8.44%7,809,448131,979,671

People Also Watch

153,800
237690
+0.85%
60,600
030200
-0.49%
90,500
000100
-1.20%
22,400
003090
-0.67%
23,750
086450
-0.63%

FAQ

What Is the Chabiotech (085660) Stock Price Today?

The Chabiotech stock price today is 16,900 KRW.

What Stock Exchange Does Chabiotech Trade On?

Chabiotech is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Chabiotech?

The stock symbol for Chabiotech is "085660."

What Is the Chabiotech Market Cap?

As of today, Chabiotech market cap is 1.56T KRW.

What Is Chabiotech's Earnings Per Share (TTM)?

The Chabiotech EPS (TTM) is -1,637.

From a Technical Analysis Perspective, Is 085660 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Chabiotech Stock Split?

Chabiotech has split 3 times.

How Many Employees Does Chabiotech Have?

Chabiotech has 278 employees.

What is the current trading status of Chabiotech (085660)?

As of May 05, 2026, Chabiotech (085660) is trading at a price of 16,900 KRW, with a previous close of 16,900 KRW. The stock has fluctuated within a day range of 16,860 KRW to 17,440 KRW, while its 52-week range spans from 9,690 KRW to 23,950 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.